Oncotarget – An Open-Access Multidisciplinary Journal

Oncotarget is an English name that means all substances and pathways that cause aging and cancer. Oncotarget itself is an open-access journal introduced in 2010. Its frequency of publishing papers is weekly. It has a Creative Commons Attribution 3.0 License. It has two able scientists at its helm.

Mikhail Blagosklonny is a professor of Oncology at the Roswell Park Cancer Institute since 2009. Andrei V Gudlov is Senior Vice President for Basic Research and Chair of Department of Cell Stress Biology in the same institution since 2007. The leadership of Oncotarget is no doubt under safe and qualified hands. Oncotarget has risen from an exclusively Oncology journal to a huge multidisciplinary journal. It now encompasses other subjects such as Pharmacology and Neuroscience. Oncotarget is published by Impact Journals

It provides a platform for individuals whose papers have been rejected in other journals to showcase their papers and receive constructive and insightful peer reviews. Indeed, it provides a platform for quick publishing of new findings. The punctuality and abundant peer-reviews provide a means for the papers to have maximal impact in the science community worldwide.

Oncotarget also sponsors the Gordon Research Conference. This is an annual conference aimed at not only showcasing new ideas and findings but also exposes the young and upcoming researchers. It gives them a chance to interact with the best researchers currently so that they learn by apprenticeship. This plays a role in preparing the next generation of researchers.In conclusion, Oncotarget is a noble journal aimed at promoting biomedical research with the aim of creating a disease free world. Follow Oncotarget journal on Twitter.